9 months ago
MIRM
AnalystsJoshua SchimmerJoshua Schimmer's Stock Forecasts
AnalystsJoshua Schimmer
Analyst Ranking
Top 1%
#39 out of 4867 analysts
Average Return
+35.96%
Win Rate
52%70 out of 135
Risk vs Reward
Poor
Good
Joshua Schimmer's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Longboard Pharmaceuticals IncLBPH | +1,051.84% | $5.17 | $59.55 | 2023-10-24 - 2024-10-23 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +986.59% | $5.52 | $59.98 | 2023-12-20 - 2024-11-29 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +963.48% | $5.64 | $59.98 | 2023-12-19 - 2024-11-29 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +227.58% | $18.31 | $59.98 | 2024-04-10 - 2024-11-29 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +200.50% | $19.96 | $59.98 | 2024-03-13 - 2024-11-29 | Strong Buy |
Joshua Schimmer Analyst Color
Get additional color on Joshua Schimmer's coverage of popular stocks
a year ago
BBIO
a year ago
LBPH
a year ago
LBPH
a year ago
VTYX
2 years ago
LBPH
Joshua Schimmer's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cg Oncology IncCGON | 4 | Strong Buy | $75.00 | +178.40% | Reiterates | 3 days ago |
Aardvark Therapeutics IncAARD | 2 | Strong Buy | $50.00 | +337.45% | Reiterates | a month ago |
Artiva Biotherapeutics IncARTV | 2 | Strong Buy | $20.00 | +716.33% | Maintains | a month ago |
Bridgebio Pharma IncBBIO | 10 | Strong Buy | $95.00 | +160.85% | Reiterates | 2 months ago |
Krystal Biotech IncKRYS | 4 | Strong Buy | $215.00 | +26.05% | Reiterates | 2 months ago |
Ascendis Pharma AASND | 2 | Buy | $260.00 | +56.08% | Maintains | 2 months ago |
Septerna IncSEPN | 2 | Strong Buy | $50.00 | +621.50% | Reiterates | 3 months ago |
Spero Therapeutics IncSPRO | 4 | Hold | $5.00 | +645.16% | Downgrades | 4 months ago |
Janux Therapeutics IncJANX | 6 | Strong Buy | $200.00 | +514.44% | Reiterates | 5 months ago |
Tourmaline Bio IncTRML | 2 | Strong Buy | $25.00 | +53.80% | Reiterates | 5 months ago |
Rocket Pharmaceuticals IncRCKT | 5 | Strong Buy | $65.00 | +792.86% | Reiterates | 5 months ago |
Ars Pharmaceuticals IncSPRY | 4 | Strong Buy | $30.00 | +115.52% | Reiterates | 7 months ago |
Longboard Pharmaceuticals IncLBPH | 15 | Strong Buy | $90.00 | +50.05% | Reiterates | 7 months ago |
Crinetics Pharmaceuticals IncCRNX | 6 | Strong Buy | $90.00 | +170.19% | Reiterates | 7 months ago |
Rallybio CorpRLYB | 3 | Buy | $15.00 | +4,834.21% | Maintains | 8 months ago |
Avidity Biosciences IncRNA | 6 | Buy | $53.00 | +64.80% | Maintains | 8 months ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $65.00 | +69.40% | Reiterates | 9 months ago |
Mirum Pharmaceuticals IncMIRM | 7 | Strong Buy | $60.00 | +41.04% | Maintains | 9 months ago |
Insmed IncINSM | 3 | Buy | $75.00 | +5.04% | Maintains | 10 months ago |
Cabaletta Bio IncCABA | 5 | Strong Buy | $50.00 | +3,806.25% | Reiterates | 10 months ago |
Ventyx Biosciences IncVTYX | 2 | Hold | $5.00 | N/A | Downgrades | a year ago |
4d Molecular Therapeutics IncFDMT | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 2 years ago |
Otis Worldwide CorpOTIS | 4 | Hold | $92.00 | N/A | Maintains | 2 years ago |
Chinook Therapeutics IncKDNY | 1 | Hold | $40.00 | N/A | Downgrades | 2 years ago |
Erasca IncERAS | 2 | Buy | $11.00 | N/A | Maintains | 2 years ago |
Bellus Health IncBLU | 3 | Hold | $14.75 | N/A | Downgrades | 2 years ago |
Atreca IncBCEL | 1 | Hold | $1.50 | N/A | Downgrades | 2 years ago |
Seagen IncSGEN | 1 | Hold | $229.00 | N/A | Downgrades | 2 years ago |
Neuphoria Therapeutics IncNEUP | 2 | Buy | $6.00 | N/A | Upgrades | 2 years ago |
Neurocrine Biosciences IncNBIX | 2 | Buy | $130.00 | N/A | Upgrades | 2 years ago |
Denali Therapeutics IncDNLI | 3 | Buy | $50.00 | N/A | Maintains | 2 years ago |
Tg Therapeutics IncTGTX | 3 | Buy | $25.00 | N/A | Maintains | 2 years ago |
Myovant Sciences LtdMYOV | 3 | Hold | $27.00 | N/A | Downgrades | 3 years ago |
Regeneron Pharmaceuticals IncREGN | 3 | Hold | $760.00 | N/A | Downgrades | 3 years ago |
Zymeworks IncZYME | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Icosavax IncICVX | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 4 years ago |
Viracta Therapeutics IncVIRX | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 4 years ago |
Biomarin Pharmaceutical IncBMRN | 2 | Buy | $100.00 | N/A | Upgrades | 4 years ago |
Cullinan Therapeutics IncCGEM | 1 | Buy | $55.00 | N/A | Initiates Coverage On | 4 years ago |
Beyondspring IncBYSI | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Freeline Therapeutics Holdings PLCFRLN | 1 | Buy | $480.00 | N/A | Initiates Coverage On | 5 years ago |
Cymabay Therapeutics IncCBAY | 1 | Buy | $15.00 | N/A | Upgrades | 5 years ago |
Bluebird Bio IncBLUE | 5 | Buy | $2,000.00 | N/A | Upgrades | 5 years ago |
Regenxbio IncRGNX | 3 | Buy | N/A | N/A | Upgrades | 6 years ago |
Madrigal Pharmaceuticals IncMDGL | 2 | Buy | $250.00 | N/A | Upgrades | 6 years ago |
Shire PLCSHPG | 2 | Hold | N/A | N/A | Downgrades | 7 years ago |
Incyte CorpINCY | 3 | Strong Buy | $85.00 | N/A | Assumes | 7 years ago |
Ionis Pharmaceuticals IncIONS | 2 | Hold | N/A | N/A | Downgrades | 7 years ago |
Voyager Therapeutics IncVYGR | 2 | Hold | N/A | N/A | Downgrades | 7 years ago |
Bioverativ IncBIVV | 3 | Hold | N/A | N/A | Downgrades | 7 years ago |
Uniqure NvQURE | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 7 years ago |
Adamas Pharmaceuticals IncADMS | 1 | Buy | $85.00 | N/A | Initiates Coverage On | 8 years ago |
Audentes Therapeutics IncBOLD1 | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Theravance Biopharma IncTBPH | 1 | Buy | N/A | N/A | Initiates Coverage On | 8 years ago |
Spark Therapeutics IncONCE | 1 | Hold | $83.00 | N/A | Initiates Coverage On | 8 years ago |
Avexis IncAVXS | 1 | Buy | $120.00 | N/A | Initiates Coverage On | 8 years ago |
Abbvie IncABBV | 1 | Buy | $95.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.